Insider · CIK 0001792018
Ryan Martins
cfoofficer
Files at ETNB (89bio, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 30, 2025 | ETNB 89bio, Inc. | AGrant or award Common Stock | +35,000 | $0.00 | $0 | 374,295 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | UTender of shares Common Stock | -374,295 | - | - | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -47,500 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -57,500 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -48,102 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -110,000 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -175,000 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -300,000 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 22, 2025 | ETNB 89bio, Inc. | MOption exercise Common Stock | +76,901 | $3.11 | $239k | 335,397 | Oct 23, 2025 |
| Oct 22, 2025 | ETNB 89bio, Inc. | MOption exercise Common Stock | +3,898 | $4.44 | $17k | 339,295 | Oct 23, 2025 |
| Oct 22, 2025 | ETNB 89bio, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -76,901 | $0.00 | $0 | 0 | Oct 23, 2025 |
| Oct 22, 2025 | ETNB 89bio, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -3,898 | $0.00 | $0 | 48,102 | Oct 23, 2025 |
| Aug 1, 2025 | ETNB 89bio, Inc. | FTax withholding Common Stock | -7,680 | $9.16 | $70k | 253,496 | Aug 5, 2025 |
| Jun 12, 2025 | ETNB 89bio, Inc. | FTax withholding Common Stock | -8,498 | $9.62 | $82k | 261,176 | Jun 13, 2025 |
| Feb 17, 2025 | ETNB 89bio, Inc. | FTax withholding Common Stock | -780 | $10.57 | $8,245 | 269,674 | Feb 19, 2025 |
| Feb 9, 2025 | ETNB 89bio, Inc. | FTax withholding Common Stock | -3,828 | $11.41 | $44k | 270,454 | Feb 11, 2025 |
| Feb 1, 2025 | ETNB 89bio, Inc. | AGrant or award Common Stock | +80,000 | $0.00 | $0 | 277,620 | Feb 4, 2025 |
| Feb 1, 2025 | ETNB 89bio, Inc. | FTax withholding Common Stock | -3,338 | $9.60 | $32k | 274,282 | Feb 4, 2025 |
| Feb 1, 2025 | ETNB 89bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +300,000 | $0.00 | $0 | 300,000 | Feb 4, 2025 |
| Dec 12, 2024 | ETNB 89bio, Inc. | AGrant or award Common Stock | -95,000 | $0.00 | $0 | 197,620 | Dec 16, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.